143 related articles for article (PubMed ID: 29891190)
1. Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma.
Mhawech-Fauceglia P; Walia S; Yessaian A; Machida H; Matsuo K; Lawrenson K
Pathology; 2018 Aug; 50(5):499-503. PubMed ID: 29891190
[TBL] [Abstract][Full Text] [Related]
2. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin 3 Expression in Endometrioid Carcinoma of the Uterine Body Correlated With Early Stage and Lower Grade.
Watanabe T; Sato K; Kono T; Yamagishi Y; Kumazawa F; Miyamoto M; Takano M; Tsuda H
Pathol Oncol Res; 2020 Oct; 26(4):2247-2253. PubMed ID: 32382899
[TBL] [Abstract][Full Text] [Related]
4. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
Lawrenson K; Pakzamir E; Liu B; Lee JM; Delgado MK; Duncan K; Gayther SA; Liu S; Roman L; Mhawech-Fauceglia P
PLoS One; 2015; 10(7):e0130909. PubMed ID: 26132201
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
7. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
8. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
Watari H; Xiong Y; Hassan MK; Sakuragi N
Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the expression of dual specificity phosphatase-1 and the prognosis of endometrioid adenocarcinoma].
Gao BR; Yao YY; Chen YH; Li XP; Wang JL; Wei LH
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2493-5. PubMed ID: 24300273
[TBL] [Abstract][Full Text] [Related]
10. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
[TBL] [Abstract][Full Text] [Related]
11. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
15. The expression of cadherin e and clinical prognostic factors in uterine endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
Georgian Med News; 2005 Nov; (128):17-21. PubMed ID: 16369055
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
[TBL] [Abstract][Full Text] [Related]
17. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
19. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
20. Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer.
Andrade DAP; da Silva VD; Matsushita GM; de Lima MA; Vieira MA; Andrade CEMC; Schmidt RL; Reis RM; Dos Reis R
PLoS One; 2019; 14(10):e0220086. PubMed ID: 31600211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
